ICON PLC (ICLR) Fundamental Analysis & Valuation

NASDAQ:ICLR • IE0005711209

Current stock price

116.5 USD
+3.44 (+3.04%)
At close:
116.5 USD
0 (0%)
After Hours:

This ICLR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. ICLR Profitability Analysis

1.1 Basic Checks

  • ICLR had positive earnings in the past year.
  • ICLR had a positive operating cash flow in the past year.
  • ICLR had positive earnings in each of the past 5 years.
  • ICLR had a positive operating cash flow in each of the past 5 years.
ICLR Yearly Net Income VS EBIT VS OCF VS FCFICLR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 3.63%, ICLR is in the better half of the industry, outperforming 75.44% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 6.42%, ICLR is in the better half of the industry, outperforming 75.44% of the companies in the same industry.
  • ICLR has a Return On Invested Capital of 6.74%. This is in the better half of the industry: ICLR outperforms 78.95% of its industry peers.
  • ICLR had an Average Return On Invested Capital over the past 3 years of 5.80%. This is significantly below the industry average of 11.38%.
  • The 3 year average ROIC (5.80%) for ICLR is below the current ROIC(6.74%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.63%
ROE 6.42%
ROIC 6.74%
ROA(3y)3.74%
ROA(5y)4.36%
ROE(3y)6.96%
ROE(5y)8.15%
ROIC(3y)5.8%
ROIC(5y)6.92%
ICLR Yearly ROA, ROE, ROICICLR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

  • ICLR's Profit Margin of 7.40% is fine compared to the rest of the industry. ICLR outperforms 73.68% of its industry peers.
  • ICLR's Profit Margin has declined in the last couple of years.
  • With a decent Operating Margin value of 13.99%, ICLR is doing good in the industry, outperforming 75.44% of the companies in the same industry.
  • In the last couple of years the Operating Margin of ICLR has remained more or less at the same level.
  • ICLR's Gross Margin of 28.15% is on the low side compared to the rest of the industry. ICLR is outperformed by 77.19% of its industry peers.
  • ICLR's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 13.99%
PM (TTM) 7.4%
GM 28.15%
OM growth 3Y9.91%
OM growth 5Y-0.95%
PM growth 3Y50.65%
PM growth 5Y-6.44%
GM growth 3Y2.3%
GM growth 5Y-0.09%
ICLR Yearly Profit, Operating, Gross MarginsICLR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. ICLR Health Analysis

2.1 Basic Checks

  • ICLR has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, ICLR has less shares outstanding
  • Compared to 5 years ago, ICLR has more shares outstanding
  • ICLR has a better debt/assets ratio than last year.
ICLR Yearly Shares OutstandingICLR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
ICLR Yearly Total Debt VS Total AssetsICLR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

  • ICLR has an Altman-Z score of 1.65. This is a bad value and indicates that ICLR is not financially healthy and even has some risk of bankruptcy.
  • ICLR's Altman-Z score of 1.65 is in line compared to the rest of the industry. ICLR outperforms 47.37% of its industry peers.
  • ICLR has a debt to FCF ratio of 3.53. This is a good value and a sign of high solvency as ICLR would need 3.53 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 3.53, ICLR is in the better half of the industry, outperforming 77.19% of the companies in the same industry.
  • ICLR has a Debt/Equity ratio of 0.31. This is a healthy value indicating a solid balance between debt and equity.
  • ICLR has a Debt to Equity ratio of 0.31. This is comparable to the rest of the industry: ICLR outperforms 49.12% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 3.53
Altman-Z 1.65
ROIC/WACC0.81
WACC8.33%
ICLR Yearly LT Debt VS Equity VS FCFICLR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.3 Liquidity

  • A Current Ratio of 1.06 indicates that ICLR should not have too much problems paying its short term obligations.
  • ICLR has a worse Current ratio (1.06) than 87.72% of its industry peers.
  • A Quick Ratio of 1.06 indicates that ICLR should not have too much problems paying its short term obligations.
  • With a Quick ratio value of 1.06, ICLR is not doing good in the industry: 80.70% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.06
Quick Ratio 1.06
ICLR Yearly Current Assets VS Current LiabilitesICLR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. ICLR Growth Analysis

3.1 Past

  • ICLR shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -5.99%.
  • The Earnings Per Share has been growing by 15.23% on average over the past years. This is quite good.
  • The Revenue has decreased by -2.46% in the past year.
  • Measured over the past years, ICLR shows a very strong growth in Revenue. The Revenue has been growing by 24.17% on average per year.
EPS 1Y (TTM)-5.99%
EPS 3Y13.76%
EPS 5Y15.23%
EPS Q2Q%-1.19%
Revenue 1Y (TTM)-2.46%
Revenue growth 3Y14.75%
Revenue growth 5Y24.17%
Sales Q2Q%0.63%

3.2 Future

  • ICLR is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 2.14% yearly.
  • ICLR is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.48% yearly.
EPS Next Y-5.55%
EPS Next 2Y-4.76%
EPS Next 3Y-0.27%
EPS Next 5Y2.14%
Revenue Next Year-2.68%
Revenue Next 2Y-1.75%
Revenue Next 3Y0.18%
Revenue Next 5Y1.48%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ICLR Yearly Revenue VS EstimatesICLR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B 8B 10B
ICLR Yearly EPS VS EstimatesICLR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10 20 30

More info and screens

Find the best growth stocksShow best growing peers

7

4. ICLR Valuation Analysis

4.1 Price/Earnings Ratio

  • ICLR is valuated reasonably with a Price/Earnings ratio of 8.83.
  • ICLR's Price/Earnings ratio is rather cheap when compared to the industry. ICLR is cheaper than 98.25% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of ICLR to the average of the S&P500 Index (27.38), we can say ICLR is valued rather cheaply.
  • The Price/Forward Earnings ratio is 9.17, which indicates a very decent valuation of ICLR.
  • ICLR's Price/Forward Earnings ratio is rather cheap when compared to the industry. ICLR is cheaper than 100.00% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 38.20, ICLR is valued rather cheaply.
Industry RankSector Rank
PE 8.83
Fwd PE 9.17
ICLR Price Earnings VS Forward Price EarningsICLR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ICLR is valued cheaper than 98.25% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of ICLR indicates a rather cheap valuation: ICLR is cheaper than 98.25% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 9.23
EV/EBITDA 7.6
ICLR Per share dataICLR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100

4.3 Compensation for Growth

  • The decent profitability rating of ICLR may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.58
EPS Next 2Y-4.76%
EPS Next 3Y-0.27%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ICLR Dividend Analysis

5.1 Amount

  • No dividends for ICLR!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ICLR Fundamentals: All Metrics, Ratios and Statistics

ICON PLC

NASDAQ:ICLR (4/15/2026, 4:46:05 PM)

After market: 116.5 0 (0%)

116.5

+3.44 (+3.04%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)10-22
Earnings (Next)04-29
Inst Owners110.05%
Inst Owner Change2.58%
Ins Owners0.66%
Ins Owner Change0%
Market Cap8.90B
Revenue(TTM)8.10B
Net Income(TTM)599.48M
Analysts75
Price Target152.55 (30.94%)
Short Float %3.82%
Short Ratio1.43
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-0.77%
Min EPS beat(2)-1.21%
Max EPS beat(2)-0.34%
EPS beat(4)1
Avg EPS beat(4)-0.63%
Min EPS beat(4)-1.21%
Max EPS beat(4)0.23%
EPS beat(8)1
Avg EPS beat(8)-2.34%
EPS beat(12)2
Avg EPS beat(12)-1.79%
EPS beat(16)5
Avg EPS beat(16)-1.4%
Revenue beat(2)1
Avg Revenue beat(2)0.4%
Min Revenue beat(2)-0.23%
Max Revenue beat(2)1.03%
Revenue beat(4)1
Avg Revenue beat(4)-0.84%
Min Revenue beat(4)-2.61%
Max Revenue beat(4)1.03%
Revenue beat(8)1
Avg Revenue beat(8)-2.24%
Revenue beat(12)1
Avg Revenue beat(12)-2.14%
Revenue beat(16)1
Avg Revenue beat(16)-2.06%
PT rev (1m)-4.36%
PT rev (3m)-27.24%
EPS NQ rev (1m)-0.68%
EPS NQ rev (3m)-2.87%
EPS NY rev (1m)-0.18%
EPS NY rev (3m)-0.9%
Revenue NQ rev (1m)-0.1%
Revenue NQ rev (3m)-0.68%
Revenue NY rev (1m)-0.01%
Revenue NY rev (3m)-0.24%
Valuation
Industry RankSector Rank
PE 8.83
Fwd PE 9.17
P/S 1.1
P/FCF 9.23
P/OCF 7.8
P/B 0.95
P/tB N/A
EV/EBITDA 7.6
EPS(TTM)13.19
EY11.32%
EPS(NY)12.7
Fwd EY10.9%
FCF(TTM)12.63
FCFY10.84%
OCF(TTM)14.93
OCFY12.82%
SpS106.11
BVpS122.25
TBVpS-38.98
PEG (NY)N/A
PEG (5Y)0.58
Graham Number190.473 (63.5%)
Profitability
Industry RankSector Rank
ROA 3.63%
ROE 6.42%
ROCE 8.53%
ROIC 6.74%
ROICexc 6.98%
ROICexgc 176.34%
OM 13.99%
PM (TTM) 7.4%
GM 28.15%
FCFM 11.9%
ROA(3y)3.74%
ROA(5y)4.36%
ROE(3y)6.96%
ROE(5y)8.15%
ROIC(3y)5.8%
ROIC(5y)6.92%
ROICexc(3y)5.97%
ROICexc(5y)8.67%
ROICexgc(3y)88.82%
ROICexgc(5y)90.84%
ROCE(3y)7.34%
ROCE(5y)8.76%
ROICexgc growth 3Y-4.45%
ROICexgc growth 5Y-5.01%
ROICexc growth 3Y27.99%
ROICexc growth 5Y-24.17%
OM growth 3Y9.91%
OM growth 5Y-0.95%
PM growth 3Y50.65%
PM growth 5Y-6.44%
GM growth 3Y2.3%
GM growth 5Y-0.09%
F-Score6
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 3.53
Debt/EBITDA 1.89
Cap/Depr 45.31%
Cap/Sales 2.17%
Interest Coverage 250
Cash Conversion 74.92%
Profit Quality 160.84%
Current Ratio 1.06
Quick Ratio 1.06
Altman-Z 1.65
F-Score6
WACC8.33%
ROIC/WACC0.81
Cap/Depr(3y)27.79%
Cap/Depr(5y)38.09%
Cap/Sales(3y)1.87%
Cap/Sales(5y)1.83%
Profit Quality(3y)130.43%
Profit Quality(5y)205.36%
High Growth Momentum
Growth
EPS 1Y (TTM)-5.99%
EPS 3Y13.76%
EPS 5Y15.23%
EPS Q2Q%-1.19%
EPS Next Y-5.55%
EPS Next 2Y-4.76%
EPS Next 3Y-0.27%
EPS Next 5Y2.14%
Revenue 1Y (TTM)-2.46%
Revenue growth 3Y14.75%
Revenue growth 5Y24.17%
Sales Q2Q%0.63%
Revenue Next Year-2.68%
Revenue Next 2Y-1.75%
Revenue Next 3Y0.18%
Revenue Next 5Y1.48%
EBIT growth 1Y-0.88%
EBIT growth 3Y26.12%
EBIT growth 5Y22.99%
EBIT Next Year0.06%
EBIT Next 3Y-0.04%
EBIT Next 5Y2.03%
FCF growth 1Y86.71%
FCF growth 3Y15.01%
FCF growth 5Y25.32%
OCF growth 1Y72.39%
OCF growth 3Y15.78%
OCF growth 5Y25.55%

ICON PLC / ICLR Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for ICON PLC?

ChartMill assigns a fundamental rating of 5 / 10 to ICLR.


What is the valuation status for ICLR stock?

ChartMill assigns a valuation rating of 7 / 10 to ICON PLC (ICLR). This can be considered as Undervalued.


What is the profitability of ICLR stock?

ICON PLC (ICLR) has a profitability rating of 6 / 10.


Can you provide the financial health for ICLR stock?

The financial health rating of ICON PLC (ICLR) is 4 / 10.